Kumaresan Ramanathan

536 total citations
38 papers, 404 citations indexed

About

Kumaresan Ramanathan is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Kumaresan Ramanathan has authored 38 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Genetics. Recurrent topics in Kumaresan Ramanathan's work include Dialysis and Renal Disease Management (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and MicroRNA in disease regulation (2 papers). Kumaresan Ramanathan is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and MicroRNA in disease regulation (2 papers). Kumaresan Ramanathan collaborates with scholars based in Ethiopia, India and United States. Kumaresan Ramanathan's co-authors include Anil G. Cashikar, Nalam Madhusudhana Rao, Suprabha Nayar, Arvind Sinha, Avijit Guha, Shashi Singh, Prashant S. Giri, Muthupandian Saravanan, Hamed Barabadi and J. Mathiyarasu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and PLANT PHYSIOLOGY.

In The Last Decade

Kumaresan Ramanathan

35 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumaresan Ramanathan Ethiopia 11 102 74 66 58 38 38 404
Alok Sharma India 13 147 1.4× 101 1.4× 46 0.7× 65 1.1× 28 0.7× 44 511
Fengping Wang China 13 147 1.4× 72 1.0× 34 0.5× 16 0.3× 48 1.3× 26 540
Lijing Xu United States 14 228 2.2× 92 1.2× 29 0.4× 44 0.8× 14 0.4× 28 621
Qiuyan Huang China 14 168 1.6× 20 0.3× 25 0.4× 36 0.6× 35 0.9× 52 580
Swati Chadha India 12 133 1.3× 55 0.7× 31 0.5× 33 0.6× 25 0.7× 14 477
Pasquale Lista Italy 8 138 1.4× 71 1.0× 16 0.2× 198 3.4× 22 0.6× 8 541
Shenglin Yang China 12 73 0.7× 30 0.4× 36 0.5× 37 0.6× 27 0.7× 31 370
Natalia Marcińczyk Poland 10 93 0.9× 37 0.5× 14 0.2× 31 0.5× 37 1.0× 26 339
Ahmed Nabil Egypt 14 98 1.0× 55 0.7× 17 0.3× 50 0.9× 58 1.5× 59 541

Countries citing papers authored by Kumaresan Ramanathan

Since Specialization
Citations

This map shows the geographic impact of Kumaresan Ramanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumaresan Ramanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumaresan Ramanathan more than expected).

Fields of papers citing papers by Kumaresan Ramanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumaresan Ramanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumaresan Ramanathan. The network helps show where Kumaresan Ramanathan may publish in the future.

Co-authorship network of co-authors of Kumaresan Ramanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Kumaresan Ramanathan. A scholar is included among the top collaborators of Kumaresan Ramanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumaresan Ramanathan. Kumaresan Ramanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramanathan, Kumaresan, et al.. (2023). Prevalence of Prediabetes and Related Modifiable Cardiovascular Risk Factors Among Employees of Ayder Comprehensive Specialized Hospital, Tigray, Northern Ethiopia. Diabetes Metabolic Syndrome and Obesity. Volume 16. 643–652. 1 indexed citations
2.
Ramanathan, Kumaresan, et al.. (2023). Long noncoding RNA: An emerging diagnostic and therapeutic target in kidney diseases. Cell Biochemistry and Function. 42(1). e3901–e3901. 5 indexed citations
3.
Suresh, C., et al.. (2020). Amperometric determination of Myo-inositol using a glassy carbon electrode modified with nanostructured copper sulfide. Microchimica Acta. 187(6). 334–334. 28 indexed citations
4.
5.
Ramanathan, Kumaresan, et al.. (2020). MiRNAs as potential biomarker of kidney diseases: A review. Cell Biochemistry and Function. 38(8). 990–1005. 25 indexed citations
6.
Ramanathan, Kumaresan, Rosalie A. Carr, Alexandra M. Roch, et al.. (2017). Splenic involvement in pancreatic adenocarcinoma may carry significant clinical impact. HPB. 19. S161–S161.
7.
8.
Ramanathan, Kumaresan, et al.. (2016). Ethnomedical survey of plants used by Malayali community to treat coronary heart diseases in Pachamalai Hills. National Journal of Physiology Pharmacy and Pharmacology. 6(4). 336–336. 2 indexed citations
9.
Ramanathan, Kumaresan, et al.. (2016). Anticancer efficacy of dry and fresh Allium ascalonicum (shallot) against HepG2 cell line. National Journal of Physiology Pharmacy and Pharmacology. 6(3). 196–196. 11 indexed citations
10.
Shanmuganathan, Rajasree, et al.. (2016). Evaluation of Interleukin 8 gene polymorphism for predicting inflammation in Indian chronic kidney disease and peritoneal dialysis patients. SHILAP Revista de lepidopterología. 53(3). 215–220. 6 indexed citations
11.
Ramanathan, Kumaresan, et al.. (2015). Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. Journal of Postgraduate Medicine. 61(4). 230–234. 25 indexed citations
12.
Akila, M., et al.. (2014). STUDY ON IN VITRO CYTOTOXICITY OF PAPAIN AGAINST LIVER CANCER CELL LINE HEP G2. International Journal of Pharmacy and Pharmaceutical Sciences. 6(9). 160–161. 3 indexed citations
13.
Ramanathan, Kumaresan, et al.. (2011). IS CYSTATIN C ESTIMATION A BETTER MARKER IN CHRONIC KIDNEY DISEASE PATIENTS. International Journal of Pharma and Bio Sciences. 1 indexed citations
14.
Ramanathan, Kumaresan, et al.. (2011). A Comparison of Serum Cystatin C and Creatinine with Glomerular FiltrationRate in Indian Patients with Chronic Kidney Disease. Oman Medical Journal. 26(6). 421–425. 20 indexed citations
15.
Guha, Avijit, Shashi Singh, Kumaresan Ramanathan, Suprabha Nayar, & Arvind Sinha. (2009). Mesenchymal cell response to nanosized biphasic calcium phosphate composites. Colloids and Surfaces B Biointerfaces. 73(1). 146–151. 49 indexed citations
16.
Ramanathan, Kumaresan & M. Parthasarathy. (2008). Utilization of Nutrients from Bajra Napier, GN Haulms or Subabul Leaves as Sole Feeds by Growing Sheep. Indian Journal of Animal Nutrition. 25(2). 142–145.
17.
Ramanathan, Kumaresan, et al.. (2008). Metabolic Influx and Energy Investment in Macrotermes convulsionarius (könig). Indian Journal of Science and Technology. 1(4). 1–8. 1 indexed citations
18.
Ramanathan, Kumaresan, et al.. (2008). Anaesthesia for Angelman syndrome. Anaesthesia. 63(6). 659–661. 15 indexed citations
19.
Buller, Chris, et al.. (2004). The profile of cardiac patients with renal artery stenosis. ACC Current Journal Review. 13(10). 34–34. 2 indexed citations
20.
Grossman, Aaron, Kumaresan Ramanathan, Parvin Justice, et al.. (1966). CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA ASSOCIATED WITH ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN A NEGRO FAMILY. PEDIATRICS. 37(4). 624–629. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alok Sharma Breakdown of academic impact, for papers by Fengping Wang Breakdown of academic impact, for papers by Lijing Xu Breakdown of academic impact, for papers by Qiuyan Huang Breakdown of academic impact, for papers by Swati Chadha Breakdown of academic impact, for papers by Pasquale Lista Breakdown of academic impact, for papers by Shenglin Yang Breakdown of academic impact, for papers by Natalia Marcińczyk Breakdown of academic impact, for papers by Ahmed Nabil
Rankless by CCL
2026